The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells

Brain Research Bulletin
Simona DamianoPaolo Mondola

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease leading to axonal injury. Even if the etiology of MS is still unknown the disease begins with inflammation involving autoreactive T lymphocytes activation in genetically susceptible subjects. Interferon beta-1b (IFN β 1b) is one of the most used drug in the MS therapy. The results obtained in this study show that the concentration of SOD1 in CSF of relapsing-remitting MS (RR-MS) patients, evaluated by enzyme-linked immunosorbent assay (ELISA), is decreased compared to pathological controls. Moreover, the Western blotting analysis demonstrated that SOD1 in human peripheral blood mononuclear cells (PBMC) in healthy controls was significantly higher compared to MS subjects before starting DMT therapy. In addition IFN β 1b therapy causes an increase of intracellular SOD1 protein as well as mRNA levels in PBMC. Moreover, the treatment of neuroblastoma SK-N-BE cells with IFN β 1b increased SOD1 protein and mRNA levels; these data also suggest that neuroprotective effect of this physiological molecule is, at least in part, carried out through its effect on SOD1. This study demonstrate that DMT therapy is able to increase SOD1 expression in PBMC of RR-MS patients. ...Continue Reading

References

Oct 1, 1994·Journal of Neuroimmunology·G C Ebers, A D Sadovnick
Nov 17, 1993·JAMA : the Journal of the American Medical Association·J R OksenbergL Steinman
Jun 1, 1996·The International Journal of Biochemistry & Cell Biology·P MondolaF Santangelo
Jun 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·A Compston
Jan 1, 1997·Epidemiologic Reviews·A D SadovnickG C Ebers
Mar 7, 2002·Journal of Neuroimmunology·Orhun H KantarciBrian G Weinshenker
Feb 8, 2003·Brain Research. Molecular Brain Research·Paolo MondolaMariarosaria Santillo
Oct 12, 2004·Biochemical and Biophysical Research Communications·Paolo MondolaLucio Annunziato
Nov 24, 2004·Lancet Neurology·Ruth Ann Marrie
Jan 7, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Bradley J TurnerSurindar S Cheema
Nov 12, 2005·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Jan 7, 2006·Journal of Manipulative and Physiological Therapeutics·Julita A Teodorczyk-InjeyanRichard Ruegg
Feb 14, 2006·Current Molecular Medicine·Bradley J Turner, Julie D Atkin
Nov 14, 2012·Molecular and Cellular Neurosciences·Simona DamianoPaolo Mondola
Apr 18, 2013·The International Journal of Neuropsychopharmacology·Silvia AlboniCarmine M Pariante
Dec 29, 2013·Trends in Molecular Medicine·Maarten E WitteJack van Horssen
Feb 20, 2014·Violence and Victims·Tricia H Witte, Mazheruddin M Mulla
Jan 7, 2015·The International Journal of Biochemistry & Cell Biology·Simona DamianoMariarosaria Santillo

❮ Previous
Next ❯

Citations

Jul 15, 2016·Biomarkers in Medicine·Richard IbitoyeAlastair Wilkins
Aug 8, 2019·International Journal of Molecular Sciences·Simona DamianoMariarosaria Santillo
Sep 16, 2020·International Journal of Molecular Sciences·Simona DamianoPaolo Mondola

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here